News: CDD Cardno Sees Fy21 EBITDA In Range Of $40 Million To $45 Million, page-20

I topped up at $0.285 (impulse buy, I splurged extra $0.005 to skip the queue at $0.28).

For profitable debt-free business it's way too cheap on these levels, and with ongoing share buybacks EPS is increasing.

Though I'm not that convinced that Crescent will pay dividend, as Germantheologist noticed they would be paying imputation credits. It makes more sense for Crescent to continue with buy backs, which will increase their relative ownership. The end game might be flogging their majority stake (at much higher price), rather than getting some money out by paying the dividends.